Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

ConclusionOverall survival of patients with BMs from CRC improved since 2014, which can be attributed to advances in chemotherapy and the more widespread use of stereotactic radiotherapy.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research